Evidence map›Paper›PMID 26183376›Full record

ArticleNature communications2015

Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1.

Sabine Vettorazzi, Constantin Bode, Lien Dejager, Lucien Frappart, Ekaterina Shelest, Carina Klaßen, Alpaslan Tasdogan, Holger M Reichardt, Claude Libert, Marion Schneider and 6 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04007328 (To Assess the Role of Sphingosine-1-phosphate in the Pathobiology of Pneumonia), which is not on this map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04007328 phase2 / phase3unknown statusnot on this mapstarted 2019, after this paper: background citation

To Assess the Role of Sphingosine-1-phosphate in the Pathobiology of Pneumonia: Generate a New Strategy for Treatment of Severe Community-acquired Pneumonia

TypeinterventionalSponsorTaipei Medical University WanFang HospitalRan2019 to 2025Enrolled400ConditionsPneumonia, BacterialArmsMethylprednisolone Sodium Succinate, Placebo
3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 149 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Protective role of zinc in the pathogenesis of respiratory diseases.European journal of clinical nutrition · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 3 countries.

Sabine VettorazziInstitute of Comparative Molecular Endocrinology (CME), Ulm University, 89081 Ulm, Germany.
Constantin BodeMolecular Cancer Research Centre (MKFZ), Charité - University Medical School (CVK), 13353 Berlin, Germany.
Lien DejagerInflammation Research Center, Mouse Genetics in Inflammation group, VIB and University Ghent, B9052 Ghent, Belgium.
Lucien FrappartDepartment of Pathology, Bat 10, HCL-Edouard Herriot Hospital, INSERM U590, 69437 Lyon, France.
Ekaterina ShelestLeibniz Institute for Natural Product Research and Infection Biology Hans Knöll Institute (HKI), 07745 Jena, Germany.
Carina KlaßenInstitute for Cellular and Molecular Immunology, University of Göttingen Medical School, 37073 Göttingen, Germany.
Alpaslan TasdoganInstitute for Immunology, Ulm University, 89081 Ulm, Germany.
Holger M ReichardtInstitute for Cellular and Molecular Immunology, University of Göttingen Medical School, 37073 Göttingen, Germany.
Claude LibertInflammation Research Center, Mouse Genetics in Inflammation group, VIB and University Ghent, B9052 Ghent, Belgium.
Marion SchneiderSection of Experimental Anesthesiology, University Clinic Ulm, 89081 Ulm, Germany.
Falk WeihLeibniz Institute for Age Research - Fritz Lipmann Institute, 07745 Jena, Germany.
N Henriette UhlenhautInstitute for Diabetes and Obesity, Helmholtz Zentrum München, 85748 Garching, Germany.
Jean-Pierre DavidDepartment of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Markus GrälerMolecular Cancer Research Centre (MKFZ), Charité - University Medical School (CVK), 13353 Berlin, Germany.
Anna KleimanLeibniz Institute for Age Research - Fritz Lipmann Institute, 07745 Jena, Germany.
Jan P TuckermannInstitute of Comparative Molecular Endocrinology (CME), Ulm University, 89081 Ulm, Germany.
Universität Ulm · DEJena University Hospital · DEUniversity of Göttingen · DEVIB-UGent Center for Inflammation Research · BECentre de Recherche en Cancérologie de Lyon · FRCharité - Universitätsmedizin Berlin · DEHelmholtz Zentrum München · DELeibniz Institute on Aging - Fritz Lipmann Institute (FLI) · DELeibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DEUniversität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute lung injury (ALI) is a severe inflammatory disease for which no specific treatment exists. As glucocorticoids have potent immunosuppressive effects, their application in ALI is currently being tested in clinical trials. However, the benefits of this type of regimen remain unclear. Here we identify a mechanism of glucocorticoid action that challenges the long-standing dogma of cytokine repression by the glucocorticoid receptor. Contrarily, synergistic gene induction of sphingosine kinase 1 (SphK1) by glucocorticoids and pro-inflammatory stimuli via the glucocorticoid receptor in macrophages increases circulating sphingosine 1-phosphate levels, which proves essential for the inhibition of inflammation. Chemical or genetic inhibition of SphK1 abrogates the therapeutic effects of glucocorticoids. Inflammatory p38 MAPK- and mitogen- and stress-activated protein kinase 1 (MSK1)-dependent pathways cooperate with glucocorticoids to upregulate SphK1 expression. Our findings support a critical role for SphK1 induction in the suppression of lung inflammation by glucocorticoids, and therefore provide rationales for effective anti-inflammatory therapies.

Indexed as

Acute Lung InjuryAnimalsChromatin ImmunoprecipitationCytokinesFlow CytometryGene Expression RegulationGlucocorticoidsInflammationLysophospholipidsMacrophagesMicep38 Mitogen-Activated Protein KinasesPhosphotransferases (Alcohol Group Acceptor)Real-Time Polymerase Chain ReactionReceptors, GlucocorticoidRibosomal Protein S6 Kinases, 90-kDaCytokinesGlucocorticoidsLysophospholipidsmitogen and stress-activated protein kinase 1p38 Mitogen-Activated Protein KinasesPhosphotransferases (Alcohol Group Acceptor)Receptors, GlucocorticoidRibosomal Protein S6 Kinases, 90-kDaSphingosinesphingosine 1-phosphateSphingosine Kinase

Identifiers

PMID26183376
PMCPMC4518295
OpenAlexW2272492043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.